Simplex Trading’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Simplex Trading’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4,900	Closed	-$171K	–	10208
2024 Q1	$171K	Sell	4,900 -47,100	-91%	-$1.72M	﹤0.01%	5032
2023 Q4	$1.98M	Buy	+52,000	New	+$1.11M	﹤0.01%	2366
2023 Q3	–	Sell	-1,800	Closed	-$46K	–	10411
2023 Q2	$46K	Buy	+1,800	New	+$42K	﹤0.01%	5932
2022 Q4	–	Sell	-200	Closed	-$3K	–	11198
2022 Q3	$3K	Buy	+200	New	+$3.6K	﹤0.01%	9212
2022 Q1	–	Sell	-3,600	Closed	-$157K	–	12033
2021 Q4	$157K	Buy	+3,600	New	+$144K	﹤0.01%	5536

Other funds holding INBX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Simplex Trading's INBX Position: Q2 2024 in Review

Simplex Trading sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 1,215 shares — an estimated $42K sold.

Simplex Trading first reported a position in INBX in Q4 2021 and held it in 6 quarters. The position peaked at $1.36M in Q4 2023. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

Simplex Trading reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Simplex Trading sold 1,215 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $42K.
Simplex Trading first reported a position in Inhibrx, Inc. Common Stock in Q4 2021 and held it in 6 quarters.
Simplex Trading's Inhibrx, Inc. Common Stock position peaked at $1.36M in Q4 2023.
2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Simplex Trading's 13F filing for Q2 2024, filed 25 Jul 2024.